全文获取类型
收费全文 | 407650篇 |
免费 | 31013篇 |
国内免费 | 11374篇 |
专业分类
耳鼻咽喉 | 2694篇 |
儿科学 | 10369篇 |
妇产科学 | 4815篇 |
基础医学 | 44548篇 |
口腔科学 | 7197篇 |
临床医学 | 37507篇 |
内科学 | 80488篇 |
皮肤病学 | 5163篇 |
神经病学 | 37939篇 |
特种医学 | 12870篇 |
外国民族医学 | 5篇 |
外科学 | 31845篇 |
综合类 | 53787篇 |
现状与发展 | 54篇 |
一般理论 | 62篇 |
预防医学 | 34867篇 |
眼科学 | 4891篇 |
药学 | 40754篇 |
244篇 | |
中国医学 | 22379篇 |
肿瘤学 | 17559篇 |
出版年
2024年 | 850篇 |
2023年 | 8215篇 |
2022年 | 15389篇 |
2021年 | 24282篇 |
2020年 | 20462篇 |
2019年 | 14124篇 |
2018年 | 14055篇 |
2017年 | 14647篇 |
2016年 | 15031篇 |
2015年 | 14317篇 |
2014年 | 22369篇 |
2013年 | 27585篇 |
2012年 | 21445篇 |
2011年 | 24355篇 |
2010年 | 17571篇 |
2009年 | 17206篇 |
2008年 | 18666篇 |
2007年 | 19274篇 |
2006年 | 17765篇 |
2005年 | 15539篇 |
2004年 | 13313篇 |
2003年 | 11669篇 |
2002年 | 9447篇 |
2001年 | 8419篇 |
2000年 | 7052篇 |
1999年 | 5997篇 |
1998年 | 5172篇 |
1997年 | 4932篇 |
1996年 | 4489篇 |
1995年 | 3942篇 |
1994年 | 3731篇 |
1993年 | 3162篇 |
1992年 | 2965篇 |
1991年 | 2722篇 |
1990年 | 2253篇 |
1989年 | 1871篇 |
1988年 | 1761篇 |
1987年 | 1610篇 |
1986年 | 1449篇 |
1985年 | 1944篇 |
1984年 | 1592篇 |
1983年 | 1110篇 |
1982年 | 1199篇 |
1981年 | 1001篇 |
1980年 | 891篇 |
1979年 | 729篇 |
1978年 | 486篇 |
1977年 | 432篇 |
1976年 | 378篇 |
1975年 | 245篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
171.
王红兰 《中国继续医学教育》2020,(13):185-187
目的观察分析在甲状腺手术患者护理中予以围术期优质护理干预的应用价值。方法此研究从本院甲状腺手术患者中选取样本,总例数为80例,研究时间始于2017年4月,止于2019年4月,依据护理方案的异同对患者进行分组,试验组予以围术期优质护理干预,对照组予以常规性护理干预,对比两组护理结果。结果研究可得,试验组护理满意率相对较高,组间数据对比得知与对照组相比统计值合理(P<0.05)。研究可得,试验组并发症发生率相对较低,组建数据对比得知与对照组相比统计值合理(P<0.05);研究可得,试验组预后生活质量相对较高,组建数据对比得知与对照组相比统计值合理(P<0.05)。结论此研究得知,在甲状腺手术患者护理中予以围术期优质护理干预,能提高患者护理效果,降低其并发症发生情况,并进一步改善患者预后效果。 相似文献
172.
《Drug metabolism and pharmacokinetics》2020,35(1):56-70
Hepatic uptake mediated by organic anion transporting polypeptide (OATP) 1B1 and 1B3 can serve as a major elimination pathway for various anionic drugs and as a site of drug-drug interactions (DDIs). This article provides an overview of the in vitro approaches used to predict human hepatic clearance (CLh) and the risk of DDIs involving OATP1Bs. On the basis of the so-called extended clearance concept, in vitro–in vivo extrapolation methods using human hepatocytes as in vitro systems have been used to predict the CLh involving OATP1B-mediated hepatic uptake. CLh can be quantitatively predicted using human donor lots possessing adequate OATP1B activities. The contribution of OATP1Bs to hepatic uptake can be estimated by the relative activity factor, the relative expression factor, or selective inhibitor approaches, which offer generally consistent outcomes. In OATP1B1 inhibition assays, substantial substrate dependency was observed. The time-dependent inhibition of OATP1B1 was also noted and may be a mechanism underlying the in vitro–in vivo differences in the inhibition constant of cyclosporine A. Although it is still challenging to quantitatively predict CLh and DDIs involving OATP1Bs from only preclinical data, understanding the utility and limitation of the current in vitro methods will pave the way for better prediction. 相似文献
173.
174.
175.
Mark Verrill 《Surgery (Oxford)》2019,37(3):181-185
Multimodality primary therapies for breast cancer combined with earlier detection have led to a sharp decline in the death rate from breast cancer in the UK over the last 40 years in the face of a rising incidence. The latest UK statistics from Cancer Research UK report 55,122 new cases of breast cancer in 2015 with 11,563 deaths from breast cancer recorded in 2016. Crudely, this equates to a cure rate of around 80% for all comers and demonstrates a clear improvement in outcome with 50,285 new cases in 2011 and 11,716 deaths in 2012. Despite this good news, there are still significant numbers of women (and men) who suffer from either a local recurrence or metastatic disease following apparently successful treatment for early breast cancer (Stage I to III). Only a minority of individuals, 6.6% with the stage recorded at diagnosis, present with stage IV disease. This review considers the treatment options available to individuals with locally recurrent and advanced breast cancer (ABC). 相似文献
176.
《Journal of the American College of Surgeons》2020,230(4):363-370
- Download : Download high-res image (207KB)
- Download : Download full-size image
177.
178.
Autoimmune thyroid diseases (AITD) and Type 1 diabetes (T1D) frequently occur in the same individual pointing to a strong shared genetic susceptibility. Indeed, the co-occurrence of T1D and AITD in the same individual is classified as a variant of the autoimmune polyglandular syndrome type 3 (designated APS3v). Our aim was to identify new genes and mechanisms causing the co-occurrence of T1D + AITD (APS3v) in the same individual using a genome-wide approach. For our discovery set we analyzed 346 Caucasian APS3v patients and 727 gender and ethnicity matched healthy controls. Genotyping was performed using the Illumina Human660W-Quad.v1. The replication set included 185 APS3v patients and 340 controls. Association analyses were performed using the PLINK program, and pathway analyses were performed using the MAGENTA software. We identified multiple signals within the HLA region and conditioning studies suggested that a few of them contributed independently to the strong association of the HLA locus with APS3v. Outside the HLA region, variants in GPR103, a gene not suggested by previous studies of APS3v, T1D, or AITD, showed genome-wide significance (p < 5 × 10−8). In addition, a locus on 1p13 containing the PTPN22 gene showed genome-wide significant associations. Pathway analysis demonstrated that cell cycle, B-cell development, CD40, and CTLA-4 signaling were the major pathways contributing to the pathogenesis of APS3v. These findings suggest that complex mechanisms involving T-cell and B-cell pathways are involved in the strong genetic association between AITD and T1D. 相似文献
179.
《Neuromodulation》2021,24(2):337-342
ObjectiveTo explore the utility of deep brain stimulation (DBS) telemedicine in the management of patients with movement disorders from January 2019 to March 2020, covering the main period of the COVID-19 outbreak in China.Materials and MethodsWe obtained data from 40 hospitals around China that employed DBS tele-programming for their outpatients with Parkinson’s disease or dystonia from January 2019 to March 2020. Data were obtained on the number and nature of patients’ DBS health care service requests, reasons for their requests, the number of DBS telemedicine sessions subsequently completed, safety issues, and the patients’ satisfaction with the DBS tele-programing parameter adjustments made.ResultsThere were 909 DBS tele-programming health service requests (from 196 patients) completed during the study period. The results showed: 1) the number of DBS telemedicine sessions requested and the number of patients examined increased during the COVID-19 outbreak in February and March 2020 when compared with the monthly numbers in 2019; 2) the most common reason for the patients’ health service requests was poor symptom control; 3) the most common DBS tele-programming adjustment made was voltage change; 4) overall, most (89%) DBS tele-programming adjustment sessions were experienced by the patients as satisfactory; and 5) significant adverse events and unexpected treatment interruptions caused by connection failure or other hardware- or software-related problems did not occur.ConclusionsDBS telemedicine could have a unique role to play in maintaining the delivery of DBS treatment and medical care to outpatients with movement disorders during the COVID-19 pandemic. 相似文献
180.